ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Update on Aveed (Nebido- testosterone undecanoate- long acting testosterone)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 1947" data-attributes="member: 3"><p><strong>Effects of 5-Year Treatment With Testosterone Undecanoate on Lower Urinary Tract Symptoms in Obese Men With Hypogonadism and Metabolic Syndrome</strong></p><p></p><p>This study showed that 5 years of Nebido (TU- testosterone undecanoate) treatment did not change International Prostate Symptom Score (IPSS), maximum urinary flow (Qmax) rate in milliliters, post-void residual (PVR) volume, or prostate size in obese hypogonadal men with metabolic syndrome and moderate lower urinary track symptoms (LUTS) at baseline. Therefore, long-term TU replacement therapy is a safe and effective treatment for reverting hypogonadal features related to metabolic syndrome and does not impact negatively on LUTS and prostate volume.</p><p></p><p><a href="http://www.goldjournal.net/article/S0090-4295(13)01046-7/abstract" target="_blank">http://www.goldjournal.net/article/S0090-4295(13)01046-7/abstract</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 1947, member: 3"] [B]Effects of 5-Year Treatment With Testosterone Undecanoate on Lower Urinary Tract Symptoms in Obese Men With Hypogonadism and Metabolic Syndrome[/B] This study showed that 5 years of Nebido (TU- testosterone undecanoate) treatment did not change International Prostate Symptom Score (IPSS), maximum urinary flow (Qmax) rate in milliliters, post-void residual (PVR) volume, or prostate size in obese hypogonadal men with metabolic syndrome and moderate lower urinary track symptoms (LUTS) at baseline. Therefore, long-term TU replacement therapy is a safe and effective treatment for reverting hypogonadal features related to metabolic syndrome and does not impact negatively on LUTS and prostate volume. [URL]http://www.goldjournal.net/article/S0090-4295(13)01046-7/abstract[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Update on Aveed (Nebido- testosterone undecanoate- long acting testosterone)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top